Augurex Life Sciences Corp. – Trademark Portfolio
Entity Type: 03
Augurex Life Sciences Corp. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include AUGUREX, JOINTSTAT, SPINESTAT, JOINT STAT, and SPINE STAT.
Unit 220, 887 Great Northern Way
Vancouver BC V5T 4T5
Showing of trademarks Trademarks
Trademark Classifications
Augurex Life Sciences Corp.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Augurex Life Sciences Corp. have?
Augurex Life Sciences Corp. has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending.
What trademark classes does Augurex Life Sciences Corp. file in?
Augurex Life Sciences Corp. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Augurex Life Sciences Corp.'s most well-known trademarks?
Augurex Life Sciences Corp.'s registered trademark portfolio includes well-known marks such as AUGUREX, JOINTSTAT, SPINESTAT, JOINT STAT, and SPINE STAT. These are among 5 currently registered trademarks in the portfolio.
What is Augurex Life Sciences Corp.'s trademark registration success rate?
Augurex Life Sciences Corp. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.